Drug Information Services
"Drug Information Services" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Services providing pharmaceutic and therapeutic drug information and consultation.
| Descriptor ID |
D004346
|
| MeSH Number(s) |
N02.421.668.320
|
| Concept/Terms |
Drug Information Services- Drug Information Services
- Information Services, Drug
- Drug Information Service
- Information Service, Drug
- Service, Drug Information
- Services, Drug Information
|
Below are MeSH descriptors whose meaning is more general than "Drug Information Services".
Below are MeSH descriptors whose meaning is more specific than "Drug Information Services".
This graph shows the total number of publications written about "Drug Information Services" by people in this website by year, and whether "Drug Information Services" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Information Services" by people in Profiles.
-
Impact of United States Food and Drug Administration's boxed warnings on adverse drug reactions reporting rates and risk mitigation for multiple myeloma drugs. Expert Opin Drug Saf. 2013 May; 12(3):299-307.
-
Impact of implementing alerts about medication black-box warnings in electronic health records. Pharmacoepidemiol Drug Saf. 2011 Feb; 20(2):192-202.
-
Comparing clinician knowledge and online information regarding Alli (Orlistat). Int J Med Inform. 2009 Nov; 78(11):772-7.
-
An effort to improve electronic health record medication list accuracy between visits: patients' and physicians' response. Int J Med Inform. 2008 Mar; 77(3):153-60.
-
A survey of factors affecting clinician acceptance of clinical decision support. BMC Med Inform Decis Mak. 2006 Feb 01; 6:6.
-
A proposal for a national program reporting beneficial drug responses, analogous to the existing program to detect adverse drug responses. Med Hypotheses. 2006; 66(1):10-3.
-
Inconsistency in DTCA practices by manufacturers: is it time to standardize print summaries? Value Health. 2004 Mar-Apr; 7(2):216-7.
-
Attitudes of physicians toward formularies and services provided by pharmacists. Manag Care Interface. 2003 Feb; 16(2):34-8.
-
Consumer involvement: effects on information processing from over-the-counter medication labels. Health Mark Q. 2001; 19(1):61-78.
-
Canadian Consensus Conference on hydroxychloroquine. J Rheumatol. 2000 Dec; 27(12):2919-21.